Role of surgery in the management of postmastectomy extremity angio sarcoma (Stewart-Treves syndrome)

Journal of Surgical Oncology

Volumn 73, Issue 3, 2000, Pages 182-188

  Grobmyer, Stephen R ^a,c   Daly, John M ^a   Glotzbach, Raymond E ^b   Grobmyer III, Albert J ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b St Francis Hospital   (United States)

^c NONE   (United States)

Author keywords

Drug therapy; Hemangiosarcoma; Lymphedema; Mastectomy; Postoperative complications; Radiotherapy

Indexed keywords

AGED; ANGIOSARCOMA; BREAST CANCER; FEMALE; HUMAN; LYMPHEDEMA; MASTECTOMY; PATHOGENESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; STEWART TREVES SYNDROME; TREATMENT OUTCOME;

EID: 0034064005     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(200003)73:3<182::AID-JSO14>3.0.CO;2-N     Document Type: Review

References (79)

1. Petrak JA, Blackwood MM: Axillary dissection: Current practice and technique. Curr Probl Surg 1995;32:312-314.
2. Stewart FW, Treves N: Lymphangiosarcoma in postmastectomy lymphedema. Cancer 1948;1:64-81.
3. Janse AJ, Coevorden FV, Peterse H, et al.: Lymphedema-induced lymphangiosarcoma. Eur J Surg Oncol 1995;21:155-158.
4. Stewart NJ, Pritchard DJ, Nascimento AG, et al.: Lymphangiosarcoma following mastectomy. Clin Orthop 1995;320:135-141.
5. DiSimone RN, El-Mahdi AM, Hazra T: The response of Stewart-Treves syndrome to radiotherapy. Radiology 1970;97:121-125.
6. Schreiber H, Barry FM, Russell WC, et al.: Stewart-Treves syndrome. Arch Surg 1979;114:82-85.
7. Tomita K, Yokogawa A, Terahata S: Lymphangiosarcoma in postmastectomy lymphedema (Stewart-Treves syndrome): Ultrastructural and immunohistologic characteristics. J Surg Oncol 1988; 38:275-282.
8. Kindblom LG, Stenman G, Angervall L: Morphological and cytogenetic studies of angiosarcoma in Stewart-Treves syndrome. Virchows Arch A Pathol Anat Histopathol 1991;419:439-445.
9. Miettinen M, Lehto VP, Virtanen I: Postmastectomy angiosarcoma (Stewart-Treves syndrome). Am J Surg Pathol 1983;7:329-339.
10. Kaufmann T, Chu F, Kaufman R: Post-mastectomy lymphangiosarcoma (Stewart-Treves syndrome): Report of two long term survivals. Br J Radiol 1991;64:857-860.
11. Sandsmark M: Angiosarcoma in post-mastectomy lymphedema. A report of one case of Stewart-Treves syndrome. Ann Chir Gynecol 1977;66:251-253.
12. Yap BS, Yap HY, McBride CM, et al.: Chemotherapy for postmastectomy lymphedema. Cancer 1981;47:853-856.
13. Gill W, Bruce SJ: Stewart-Treves syndrome. J R Coll Surg Edinb 1968;13:34-39.
14. Woodward AH, Ivins JC, Soule EH: Lymphangiosarcoma arising in chronic lymphedematous extremities. Cancer 1972;30:562-572.
15. Martin MB, Kon ND, Kawamoto EH, et al.: Postmastectomy angiosarcoma. Am Surg 1984;50:541-545.
16. Bachulis BL, Old JW, James AG: Postmastectomy lymphangiosarcoma in a patient with carcinoma of the rectum. Am J Surg 1967;113:289-291.
17. Fisher JH: Postmastectomy lymphangiosarcoma in the lymphedematous arm: A review of four cases. Can J Surg 1965;8:350-357.
18. Fitzpatrick PJ: Lymphangiosarcoma and breast cancer. Can J Surg 1968;12:172-177.
19. Barnett WO, Hardy JD, Hendrix JH: Lymphangiosarcoma following post-mastectomy lymphedema. Ann Surg 1969;169:960-968.
20. McSwain B, Whitehead W, Bennett L: Angiosarcoma: Report of three cases of postmastectomy lymphangiosarcoma and one hemangiosarcoma. South Med J 1973;66:102-106.
21. Tragus ET, Wagner DE: Current therapy for postmastectomy lymphangiosarcoma. Arch Surg 1968;97:839-842.
22. Alessi E, Sala F, Berti E: Angiosarcoma in lymphedematous limbs. Am J Dermatopathol 1986;8:371-378.
23. Offori TW, Platt CC, Stephens M, et al.: Angiosarcoma in congenital hereditary lymphedema (Milroy's disease) - Diagnostic beacons and a review of the literature. Clin Exp Dermatol 1992; 18:174-177.
24. Kirchmann TT, Smoller BR, McGuire J: Cutaneous angiosarcoma as a second malignancy in a lymphedematous leg in a Hodgkin's disease survivor. J Am Acad Dermatol 1994;31:861-866.
25. Goette DK, Detlefs RL: Postirradiation angiosarcoma. J Am Acad Dermatol 1985;12:922-926.
26. Baes H: Angiosarcoma in a chronic lymphedematous leg. Dermatologica 1967;134:331-336.
27. Maddox JC, Evans HL: Angiosarcoma of the skin and soft tissue: A study of forty-four cases. Cancer 1981;48:1907-1921.
28. Girard C, Johnson WC, Graham J: Cutaneous angiosarcoma. Cancer 1970;26:868-883.
29. Muller R, Hajdu SI, Brennan MF: Lymphangiosarcoma associated with chronic filarial lymphedema. Cancer 1987;59:179-183.
30. Scully RE, Mark EJ, McNeely WF, et al.: Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 18-1993. A 57-year old man with chronic lymphedema and enlarging purple cutaneous nodules of the leg. N Engl J Med 1993;328:1337-1343.
31. Brady MS, Garfein CF, Petrek JA, et al.: Post-treatment sarcoma in breast cancer patients. Ann Surg Oncol 1994;1:66-72.
32. Williams EV, Banerjee D, Dallimore N, et al.: Angiosarcoma of the breast following radiation therapy. Eur J Surg Oncol 1999;25: 221-227.
33. Eby CS, Brennan MJ, Fine G: Lymphangiosarcoma: A lethal complication of chronic lymphedema. Arch Surg 1967;94:223-230.
34. Sordillo PP, Chapman R, Hajdu SI, et al.: Lymphangiosarcoma. Cancer 1981;48:1674-1679.
35. Khodadadeh M, Johnson R, Zeiders GW: Lymphangiosarcoma arising from postmastectomy lymphedema. JAMA 1963;186:131-133.
36. Lambert PB, Frank HA, Bellman S: The role of lymphatic trunks in the response to allogenic skin transplants. Transplantation 1965;3:62-73.
37. Futrell JW, Meyers GH: The regional lymphatics and cancer immunity. Ann Surg 1973;177:1-11.
38. Stark RB, Dwyer EM, DeForest M: Effects of surgical ablation of regional lymph nodes on survival of skin homografts. Ann NY Acad Sci 1960;87:140-148.
39. Mallon E, Posell S, Mortimer P, et al.: Evidence for altered cell-mediated immunity in postmastectomy lymphedema. Br J Dermatol 1997;137:928-933.
40. Kissin MW, Querci della Rovere G, Easton D, et al.: Risk of lymphoedema following the treatment of breast cancer. Br J Surg 1986;73:580-584.
41. Pezner RD, Patterson MP, Hill LR, et al.: Arm lymphedema in patients treated conservatively for breast cancer: Relationship to patient age and axillary node dissection technique. Int J Radiat Oncol Biol Phys 1986;12:2079-2083.
42. Dauway EL, Giuliano R, Haddad F, et al.: Lymphatic mapping in breast cancer. Hematol Oncol Clin North Am 1999;13:349-371.
43. Wilhelm MC, Saul PB, Morgan JA: Post-mastectomy lymphedema. Va Med 1974;101:465-469.
44. Holthofer H, Virtanen I, Kariniemi AL, et al.: Ulex europaeus I lectin as a marker for vascular endothelium in human tissues. Lab Invest 1982;47:60-66.
45. Hultberg BM: Angiosarcomas in chronically lymphedematous extremities. Am J Dermatopathol 1987;9:406-412.
46. Benda JA, Al-Jurf AS, Benson AB: Angiosarcoma of the breast following segmental mastectomy complicated by lymphedema. Am J Clin Pathol 1987;87:651-655.
47. Mullick SS, Mody DR, Schwartz MR: Angiosarcoma at unusual sites. A report of two cases with aspiration cytology at unusual sites. Acta Cytol 1997;41:839-844.
48. Capo V, Ozzello L, Fenoglio CM, et al.: Angiosarcomas arising in edematous extremities: Immunostaining for factor VIII-related antigen and ultrastructural features. Hum Pathol 1985;16:144-150.
49. Breiteneder-Geleff S, Soleiman A, Kowalski H, et al.: Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries. Am J Pathol 1999;154:385-394.
50. Jeltsch M, Kaipainen A, Joukov V, et al.: Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 1997;276: 1423-1425.
51. Smith L: Post-mastectomy angiosarcoma: Case report and review of the literature. Tex Med 1984;80:43-44.
52. Kazerooni E, Hessler C: CT appearance of angiosarcoma associated with chronic lymphedema. AJR Am J Roentgenol 1991;156: 543-544.
53. Diaz-Cascajo C, Vega MDL, Rey-Lopez A: Superinfected cutaneous angiosarcoma: A highly malignant neoplasm simulating an inflammatory process. J Cutan Pathol 1997;24:56-60.
54. Dubin HV, Creehan P, Headington JT: Lymphangiosarcoma and congenital lymphedema of the extremity. Arch Dermatol 1974; 110:608-614.
55. Kissin MW, Fisher C, Webb AJ, et al.: Value of fine needle aspiration cytology in the diagnosis of soft tissue tumors: A preliminary study on the excised specimen. Br J Surg 1987;74:479-480.
56. Oettle AG, Blerk PV: Postmastectomy lymphostatic endothelioma of Stewart-Treves in a male. Br J Surg 1963;50:736-743.
57. Hermann JB: Lymphangiosarcoma of the chronically edematous extremity. Surg Gynecol Obstet 1965;121:1107-1115.
58. Lewis JJ, Brennan MF: Soft tissue sarcomas. Curr Probl Surg 1996;33:817-872.
59. Fong Y, Coit DG, Woodruff JM, et al.: Lymph node metastasis from soft tissue sarcoma in adults. Ann Surg 1993;217:72-77.
60. McConnell EM, Haslam P: Angiosarcoma in post-mastectomy lymphoedema: A report of 5 cases and review of the literature. Br J Surg 1959;46:322-327.
61. Pisters PT: Combined modality treatment of extremity soft tissue sarcomas. Ann Surg Oncol 1998;5:464-472.
62. Southwick H, Slaughter DP: Lymphangiosarcoma in postmastectomy lymphedema. Cancer 1955;8:158-160.
63. Hermann JB, Ariel IM: Therapy of lymphangiosarcoma of the clinically edematous limb: Five year cure of a patient treated with intra-arterial radioactive yttrium. AJR Am J Roentgenol 1967;99: 393-399.
64. Brennan MF, Caspers ES, Harrison LB, et al.: The role of multi-modality therapy in soft tissue sarcoma. Ann Surg 1991;214:328-336.
65. Harrison LB, Franzese F, Gaynor JJ, et al.: Long term results of a prospective trial of adjuvant brachytherapy in the management of completely resected soft tissue sarcomas of the extremity and superficial trunk. Int J Radiat Oncol Biol Phys 1993;27:259-265.
66. McBride CM, Reeder JW, Smith JL: Angiosarcoma in the lymphedematous limb. South Med J 1969;62:378-380.
67. Naka N, Ohsawa M, Tomita Y, et al.: Prognostic factors in angiosarcoma: A multivariate analysis of 55 cases. J Surg Oncol 1996;61:170-176.
68. Furue M, Yamada N, Takahashi T, et al.: Immunotherapy for Stewart Treves syndrome. J Am Acad Dermatol 1994;30:899-903.
69. Reubi JC, Waser B, Laissue JA, et al.: Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: In vitro identification. Cancer Res 1996;56:1922-1931.
70. Eary JF, Conrad EU, Bruckner JD, et al.: Quantitative fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcomas. Clin Cancer Res 1998;4:1215-1220.
71. Lucas JD, O'Doherty MJ, Cronin BF, et al.: Prospective evaluation of soft-tissue masses and sarcomas using fluorodeoxyglucose positron emission tomography. Br J Surg 1999;86:550-556.
72. Steele RJ, Thompson AM, Hall PA, et al.: The p53 tumour suppressor gene. Br J Surg 1998;85:1460-1467.
73. Donehower LA, Harvey M, Slagle BL, et al.: Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992;356:215-221.
74. Zietz C, Rossle M, Haas C, et al.: MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas. Am J Pathol 1998;153:1425-1433.
75. McNamara DA, Harmey JH, Walsh TN, et al.: Significance of angiogenesis in cancer therapy. Br J Surg 1998;85:1044-1045.
76. Folkman J: Tumor angiogenesis: Therapeutic implications. N Engl J Med 1971;285:1182-1186.
77. Ferrara N: The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat 1995;36:127-137.
78. Hashimoto M, Ohsawa M, Ohnishi A, et al.: Expression of vascular endothelial growth factor and its receptor mRNA in angiosarcoma. Lab Invest 1995;73:859-863.
79. Billingsley KG, Burt ME, Jara E, et al.: Pulmonary metastases from soft tissue sarcoma. Ann Surg 1999;229:602-612.